Nevada
Provider Communications
Anti-VEGF Medical Step Therapy Notice
The clinical criteria below will be updated to include the requirement of a preferred agent effective
January 1, 2021.
Clinical Criteria |
Status |
Drug(s) |
HCPCS Codes |
ING-CC-0072 |
Preferred |
Avastin |
J9035, C9257 |
ING-CC-0072 |
Preferred |
Mvasi |
Q5107 |
ING-CC-0072 |
Preferred |
Zirabev |
Q5118 |
ING-CC-0072 |
Non-preferred |
Eylea |
J0178 |
ING-CC-0072 |
Non-preferred |
Lucentis |
J2778 |
ING-CC-0072 |
Non-preferred |
Macugen |
J2503 |
ING-CC-0072 |
Non-preferred |
Beovu |
J0179 |
The clinical criteria is publicly available on our website at https://mediproviders.anthem.com/nv.
What if I need assistance?
If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-844-396-2330.
Featured In:
December 2020 Anthem Provider News and Important Updates -- Nevada